IL1B and diabetes mellitus: Anti-inflammatory treatments, including minocycline or baicalein, attenuate the upregulation of IL-1β and TNF-α and confer retinal protection in animal models of diabetes as demonstrated by reductions in neuronal loss, capillary loss, and vascular leakage77,80.